-
公开(公告)号:US20230337677A1
公开(公告)日:2023-10-26
申请号:US17635631
申请日:2020-08-28
IPC分类号: A01N47/20 , C07C311/08 , A01N53/00 , A01N43/647 , A01N37/16 , A01N37/22 , C07C69/017 , C07D209/48 , C07C233/25 , A01P17/00 , A01N43/18 , C07D213/74 , C07C69/747 , A01N43/82 , C07D271/12 , C07D213/75 , A01N25/18 , C07C233/91 , A01N37/10 , C07D213/76 , C07D335/02 , A01N43/40 , C07C271/64 , C07D249/18 , A01N43/38 , A01N41/10 , C07C233/43 , C07C271/28 , C07C233/15 , C07C255/29 , C07C233/05 , A01N37/26 , C07C233/44 , C07C233/66
CPC分类号: A01N47/20 , C07C311/08 , A01N53/00 , A01N43/647 , A01N37/16 , A01N37/22 , C07C69/017 , C07D209/48 , C07C233/25 , A01P17/00 , A01N43/18 , C07D213/74 , C07C69/747 , A01N43/82 , C07D271/12 , C07D213/75 , A01N25/18 , C07C233/91 , A01N37/10 , C07D213/76 , C07D335/02 , A01N43/40 , C07C271/64 , C07D249/18 , A01N43/38 , A01N41/10 , C07C233/43 , C07C271/28 , C07C233/15 , C07C255/29 , C07C233/05 , A01N37/26 , C07C233/44 , C07C233/66 , C07C2601/10 , C07C2601/02
摘要: The subject matter described herein is directed to compounds, synergistic compositions, and methods for repelling arthropods, such as insects. The compositions comprise aryl and pyridyl-type compounds. The compounds demonstrate strong vapor and topical repellency when applied alone and in synergistic compositions.
-
2.
公开(公告)号:US20230146507A1
公开(公告)日:2023-05-11
申请号:US17913490
申请日:2021-03-23
发明人: Rolf W. Hartmann , Jelena Konstantinovic , Jörg Haupenthal , Anna K. Hirsch , Andreas M. Kany , Cansu Kaya , Samir Yahiaoui , Thomas Wichelhaus , Eugen Proschak
IPC分类号: A61K31/196 , A61K31/407 , C07C323/41 , C07C311/08 , C07C311/46 , C07C311/58 , C07C311/64 , C07D295/26 , C07D295/135 , A61K31/18 , A61K31/167 , A61K31/245 , A61K31/64 , A61K31/5375 , A61K31/495 , A61P31/04
CPC分类号: A61K31/196 , A61K31/407 , C07C323/41 , C07C311/08 , C07C311/46 , C07C311/58 , C07C311/64 , C07D295/26 , C07D295/135 , A61K31/18 , A61K31/167 , A61K31/245 , A61K31/64 , A61K31/5375 , A61K31/495 , A61P31/04
摘要: The present invention related to novel inhibitors of metallo-β3-lactamases of formula (I)
wherein R1 is an optionally substituted aryl group of an optionally substituted heteroaryl group, and the use thereof in the treatment of bacterial infections, especially in combination with β-lactam antibiotics.-
公开(公告)号:US20220227750A1
公开(公告)日:2022-07-21
申请号:US17649133
申请日:2022-01-27
申请人: Baylor College of Medicine , The United States of America, as represented by the Secretary, Department of Health and Human Servic
IPC分类号: C07D417/12 , A61K31/18 , A61K31/381 , A61K31/505 , A61K45/06 , A61K31/196 , A61K31/4196 , A61K31/357 , A61K31/415 , A61K31/403 , C07C311/08 , C07C311/21 , C07C311/29 , C07D213/71 , C07D215/36 , C07D239/545 , C07D319/18 , C07D333/34 , C07D401/12 , C07D409/12 , C07D413/12
摘要: Embodiments of the invention include methods of preventing and/or reducing the risk or severity of an allergic reaction in an individual. In some embodiments, particular small molecules are employed for prevention and/or reduction in the risk or severity of anaphylaxis. In at least particular cases, the small molecules are inhibitors of STAT3. In some cases, the small molecule comprises N-(1′,2-dihydroxy-1,2′-binaphthalen-4′-yl)-4-methoxybenzenesulfonamide.
-
公开(公告)号:US20220227720A1
公开(公告)日:2022-07-21
申请号:US17609135
申请日:2020-05-06
发明人: Chris Meier , Matthias Winkler , Katharina Pfaff , Nora Constanze Fohrmann , Gilles Querat , Xavier de Lamballerie
IPC分类号: C07D265/22 , C07C235/24 , C07C321/28 , C07C233/54 , A61P31/12 , C07C271/28 , C07C275/42 , C07D209/08 , C07D213/79 , C07D317/46 , C07D235/08 , C07D239/96 , C07C311/08
摘要: The present invention relates to a compound, or a dimer or a pharmaceutically acceptable salt or solvate of said compound or dimer, for use in a method for the treatment of a disease, disorder or condition caused by an RNA virus, said compound having the general structure shown in Formula (I).
-
公开(公告)号:US20220055985A1
公开(公告)日:2022-02-24
申请号:US17463011
申请日:2021-08-31
发明人: Julie FARAND , Joshua A. KAPLAN , Gregory NOTTE , Casey Lockwood OLEN , Michael SANGI , David SPERANDIO
IPC分类号: C07C323/25 , C07C323/30 , C07C323/31 , C07D205/04 , C07D207/48 , C07D213/89 , C07D231/18 , C07D235/00 , C07D239/26 , C07D257/04 , C07D275/02 , C07D277/36 , C07D295/116 , C07D305/08 , C07D309/08 , C07D335/02 , C07D451/02 , C07D493/08 , C07F9/50 , C07C313/06 , A61K31/18 , C07C311/08 , C07C311/21 , C07C311/39 , C07C311/29 , C07C311/46 , C07C311/14 , C07C311/13
摘要: Provided is a compound of Formula (I): wherein the variable groups are defined herein.
-
公开(公告)号:US10662192B2
公开(公告)日:2020-05-26
申请号:US16006105
申请日:2018-06-12
发明人: Sara Hadida-Ruah , Anna Hazlewood , Peter Grootenhuis , Fredrick Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
IPC分类号: C07C205/11 , C07C205/58 , C07D471/10 , C07C211/17 , C07C209/00 , C07C215/28 , C07D209/08 , C07D209/14 , C07D209/18 , C07D209/42 , C07D209/94 , C07D213/20 , C07D213/73 , C07D215/227 , C07D215/38 , C07D217/06 , C07D223/16 , C07D265/36 , C07D279/16 , C07D311/58 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07C215/76 , C07D215/56 , C07D401/12 , C07D215/233 , A61K8/49 , A61K31/47 , A61K31/4709 , A61K45/06 , C07C215/78 , C07C217/84 , C07D209/12 , C07D209/20 , A61K31/136 , A61K31/265 , A61K31/352 , A61K31/404 , A61K31/4045 , A61K31/4747 , A61K31/55 , C07C219/34 , G01N33/566 , G01N33/487 , G01N33/50 , G01N33/68 , C07C217/80 , C07C229/52 , A61K31/04 , A61K31/27 , A61K31/277 , A61K31/403 , A61K31/44 , A61K31/472 , A61K31/538 , A61K31/5415 , C07C211/50 , C07C211/52 , C07C215/70 , C07C217/76 , C07C255/58 , C07C271/20 , C07C311/08 , C07C311/39 , C07D209/04 , C07D209/96 , C07D217/04
摘要: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
公开(公告)号:US20180044288A1
公开(公告)日:2018-02-15
申请号:US15726241
申请日:2017-10-05
发明人: Thomas Matthew BAKER , Matthew Colin Thor FYFE , Gareth William HARBOTTLE , Vedran HASIMBEGOVIC , Premji MEGHANI , Aaron RIGBY , Colin SAMBROOK-SMITH , Stephen Malcolm THOM
IPC分类号: C07C317/48 , A61K31/444 , A61K31/4427 , A61K31/505 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K31/553 , C07C311/08 , C07C317/28 , C07D211/86 , C07D213/74 , C07D233/90 , C07D239/47 , C07D401/12 , C07D403/12 , C07D405/12 , A61K31/44 , C07D405/14 , C07D413/12
CPC分类号: C07C317/48 , A61K31/44 , A61K31/4427 , A61K31/444 , A61K31/505 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K31/553 , C07C311/08 , C07C317/28 , C07D211/86 , C07D213/74 , C07D233/90 , C07D239/47 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12
摘要: There are provided compounds of formula I, wherein R1A to R1E, R2 to R5, L and X1 to X3 have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.
-
公开(公告)号:US09856214B2
公开(公告)日:2018-01-02
申请号:US15036211
申请日:2014-11-14
发明人: Troy E. Messick , Garry R. Smith , Allen B. Reitz , Paul M. Lieberman , Mark E. McDonnell , Yan Zhang , Venkata Velvadapu
IPC分类号: A61K31/405 , A61K31/41 , A61K31/42 , C07D209/42 , C07D401/00 , C07D403/00 , C07D207/327 , C07C229/56 , C07C255/54 , C07C255/55 , C07C211/27 , C07C217/84 , C07C233/11 , C07C233/64 , C07C233/65 , C07C235/58 , C07C311/08 , C07C311/16 , C07C311/17 , C07C317/14 , C07D235/06 , C07D403/10 , C07D239/26 , C07D409/10 , C07D417/10 , C07D471/04 , C07D487/04 , C07D209/08 , C07D295/155 , C07D213/55 , C07C53/18 , C07C63/66 , C07C65/19 , C07C65/28 , C07C229/64 , C07C317/44 , C07D207/08 , C07D207/12 , C07D207/14 , C07D207/16 , C07D211/70 , C07D213/64 , C07D213/74 , C07D215/14 , C07D231/12 , C07D249/06 , C07D277/30 , C07D307/79 , C07D333/54 , C07D401/04 , C07D401/10
CPC分类号: C07D207/327 , C07C53/18 , C07C63/66 , C07C65/19 , C07C65/28 , C07C211/27 , C07C217/84 , C07C229/56 , C07C229/64 , C07C233/11 , C07C233/64 , C07C233/65 , C07C235/58 , C07C255/54 , C07C255/55 , C07C311/08 , C07C311/16 , C07C311/17 , C07C317/14 , C07C317/44 , C07C2601/02 , C07D207/08 , C07D207/12 , C07D207/14 , C07D207/16 , C07D209/08 , C07D211/70 , C07D213/55 , C07D213/64 , C07D213/74 , C07D215/14 , C07D231/12 , C07D235/06 , C07D239/26 , C07D249/06 , C07D277/30 , C07D295/155 , C07D307/79 , C07D333/54 , C07D401/04 , C07D401/10 , C07D403/10 , C07D409/10 , C07D417/10 , C07D471/04 , C07D487/04
摘要: The invention provides EBNA1 inhibitors, and pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by EBNA1 activity such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The compounds and compositions of the invention are further useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection. The compounds and compositions of the invention are further useful for the treatment of diseases caused by lytic EBV infection.
-
公开(公告)号:US20170334841A1
公开(公告)日:2017-11-23
申请号:US15446831
申请日:2017-03-01
发明人: Yonghong Deng , Louis Plamondon , Cuixiang Sun , Xiao-Yi Xiao , Jingye Zhou , Joyce A. Sutcliffe , Magnus P. Ronn
IPC分类号: C07C311/08 , C07D295/15 , C07C237/26 , C07C307/10 , C07C311/09 , C07C311/13 , C07C311/21 , C07C311/29 , C07C311/44 , C07D233/84 , C07D233/60 , C07D231/18 , C07D223/06 , C07D213/82 , C07D213/74 , C07D213/70 , C07D211/60 , C07D211/54 , C07D209/52 , C07D209/44 , C07D207/16 , C07D207/12 , C07D205/04 , C07D307/64 , C07C2603/46 , C07C2601/02 , C07C2603/40 , C07C2603/44 , C07C2601/16 , C07C2601/04 , C07C2601/14 , C07C2601/08
CPC分类号: C07C311/08 , C07C237/26 , C07C307/10 , C07C311/09 , C07C311/13 , C07C311/21 , C07C311/29 , C07C311/44 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/16 , C07C2603/40 , C07C2603/44 , C07C2603/46 , C07D205/04 , C07D207/12 , C07D207/16 , C07D209/44 , C07D209/52 , C07D211/54 , C07D211/60 , C07D213/70 , C07D213/74 , C07D213/82 , C07D223/06 , C07D231/18 , C07D233/60 , C07D233/84 , C07D295/15 , C07D307/64
摘要: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
-
10.
公开(公告)号:US09795139B2
公开(公告)日:2017-10-24
申请号:US15092641
申请日:2016-04-07
申请人: Dow AgroSciences LLC
发明人: Joseph D. Eckelbarger , Daniel I. Knueppel , Ronald J. Heemstra , Ronald Ross, Jr. , Kyle A. Dekorver , Kaitlyn Gray , Peter Vednor , Timothy P. Martin , Ricky Hunter , David A. Demeter , Tony K. Trullinger , Erich Baum , Zoltan L. Benko , Nakyen Choy , Gary Crouse , John F. Daeuble, Sr. , Fangzheng Li , Jeff Nissen , Michelle Riener , Tom Sparks , Frank Wessels , Maurice Yap
IPC分类号: A01N53/00 , A01N43/90 , C07D207/273 , A01N43/82 , C07D307/33 , C07D277/36 , C07D263/26 , C07D261/12 , C07D333/48 , C07D307/52 , C07D277/30 , C07D213/56 , C07C237/22 , C07D333/60 , C07D233/80 , C07D487/04 , A01N43/707 , A01N43/653 , A01N43/60 , A01N43/40 , A01N41/10 , A01N37/34 , A01N37/22 , C07D253/07 , C07D241/20 , C07C317/14 , C07C233/65 , C07C233/63 , C07D209/49 , C07C381/10 , C07D205/04 , C07C237/42 , C07D207/10 , C07D207/452 , C07C255/29 , C07C255/57 , C07D285/06 , C07D295/32 , C07D305/08 , C07C255/46 , C07D213/75 , C07C255/60 , C07C259/10 , C07D213/81 , C07D213/84 , C07D309/14 , C07D213/89 , C07D215/227 , C07C271/28 , C07C271/66 , C07D215/38 , C07D231/12 , C07D331/04 , C07D231/56 , C07D333/36 , C07D233/36 , C07C311/08 , C07C311/46 , C07D235/30 , C07C317/28 , C07C317/40 , C07C317/50 , C07C323/41 , C07C323/42 , C07C323/59 , C07D249/08 , C07C331/12
CPC分类号: A01N53/00 , A01N37/22 , A01N37/34 , A01N41/10 , A01N43/40 , A01N43/60 , A01N43/653 , A01N43/707 , A01N43/82 , A01N43/90 , C07C233/63 , C07C233/65 , C07C237/22 , C07C237/42 , C07C255/29 , C07C255/46 , C07C255/57 , C07C255/60 , C07C259/10 , C07C271/28 , C07C271/66 , C07C311/08 , C07C311/46 , C07C317/14 , C07C317/28 , C07C317/40 , C07C317/50 , C07C323/41 , C07C323/42 , C07C323/59 , C07C331/12 , C07C381/10 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D205/04 , C07D207/10 , C07D207/273 , C07D207/452 , C07D209/49 , C07D213/56 , C07D213/75 , C07D213/81 , C07D213/84 , C07D213/89 , C07D215/227 , C07D215/38 , C07D231/12 , C07D231/56 , C07D233/36 , C07D233/80 , C07D235/30 , C07D241/20 , C07D249/08 , C07D253/07 , C07D261/12 , C07D263/26 , C07D277/30 , C07D277/36 , C07D285/06 , C07D295/32 , C07D305/08 , C07D307/33 , C07D307/52 , C07D309/14 , C07D331/04 , C07D333/36 , C07D333/48 , C07D333/60 , C07D487/04
摘要: This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).
-
-
-
-
-
-
-
-
-